| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider activity in TNXP over the last quarter tilts toward buying: insiders added a net 3,000 shares worth roughly $40K.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 11.0K | $57.1K | - | |
| Dir | 5.0K | $26.0K | - | |
| CFO | 2.2K | $11.2K | - | |
| Dir | 1.8K | $9.5K | - | |
| Dir | 1.0K | $5.2K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 29, 2022 | Seth Lederman | Chief Executive Officer | Buy | 20,000 | $1.71 | $34,200.00 | +472.3% | -67.7% | -84.6% | |
| Mar 25, 2022 | Seth Lederman | Chief Executive Officer | Buy | 100,000 | $0.25 | $24,500.00 | +821.2% | -73.0% | -92.2% | |
| Sep 28, 2021 | Seth Lederman | Chief Executive Officer | Buy | 12,000 | $0.61 | $7,320.00 | +6,780% | -33.5% | -97.0% | |
| May 25, 2021 | Daniel Wintner Goodman | Director | Buy | 5,000 | $1.12 | $5,600.00 | +500,000% | -38.4% | -94.4% | |
| Mar 24, 2021 | Seth Lederman | Chief Executive Officer | Buy | 16,733 | $1.32 | $22,087.56 | +14.1% | -10.5% | -80.8% | |
| Dec 30, 2020 | Seth Lederman | Chief Executive Officer | Buy | 35,000 | $0.68 | $23,800.00 | +42.0% | - | - | |
| Aug 31, 2020 | James Treco | Director | Buy | 5,500 | $0.89 | $4,895.00 | +122.2% | - | - | |
| Aug 20, 2020 | Margaret Smith Bell | Director | Buy | 5,391 | $0.93 | $4,997.46 | New | - | - | |
| Aug 17, 2020 | Gregory M Sullivan | Chief Medical Officer | Buy | 20,000 | $1.03 | $20,600.00 | +1,423% | - | - | |
| Aug 14, 2020 | James Treco | Director | Buy | 4,500 | $1.06 | $4,770.00 | New | - | - |